Exploring HER2 Positive Diagnostic Criteria in High-grade Serous Ovarian Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Exploring HER2 Positive Diagnostic Criteria in High-grade Serous Ovarian Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06883487

Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary

Ovarian cancer is the most lethal gynecological malignancy, and 70% of ovarian cancer patients are diagnosed late at the time of new diagnosis. Even after syste…

China144 participantsStarted 2024-04-07

Treatment: No intervention

Exploring HER2 Positive Diagnostic Criteria in High-grade Serous Ovarian Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary

All recent trials (1 shown)